APA (7th ed.) Citation

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, & Simone Ribero. (2022). Seven cancer patients receiving Guselkumab for treatment of moderate-to-severe psoriasis. PAGEPress Publications.

Chicago Style (17th ed.) Citation

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, and Simone Ribero. Seven Cancer Patients Receiving Guselkumab for Treatment of Moderate-to-severe Psoriasis. PAGEPress Publications, 2022.

MLA (9th ed.) Citation

Luca Mastorino, et al. Seven Cancer Patients Receiving Guselkumab for Treatment of Moderate-to-severe Psoriasis. PAGEPress Publications, 2022.